Fernwood Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$407K Sell
2,660
-100
-4% -$16.9K 0.14% 119
2024
Q3
$535K Sell
2,760
-120
-4% -$25.1K 0.17% 113
2024
Q2
$668K Sell
2,880
-3
-0.1% -$652 0.21% 92
2024
Q1
$622K Buy
2,883
+3
+0.1% +$703 0.18% 106
2023
Q4
$745K Hold
2,880
0.25% 88
2023
Q3
$740K Sell
2,880
-200
-6% -$53.5K 0.27% 89
2023
Q2
$877K Sell
3,080
-100
-3% -$29.8K 0.31% 87
2023
Q1
$884K Sell
3,180
-1,250
-28% -$346K 0.34% 83
2022
Q4
$1.23M Sell
4,430
-400
-8% -$113K 0.51% 62
2022
Q3
$1.29M Sell
4,830
-209
-4% -$44.4K 0.54% 53
2022
Q2
$1.03M Hold
5,039
0.44% 68
2022
Q1
$1.06M Sell
5,039
-215
-4% -$46.8K 0.37% 77
2021
Q4
$1.26M Buy
5,254
+9
+0.2% +$2.31K 0.41% 69
2021
Q3
$1.48M Sell
5,245
-15
-0.3% -$4.92K 0.51% 57
2021
Q2
$1.82M Sell
5,260
-225
-4% -$68.2K 0.6% 47
2021
Q1
$1.53M Sell
5,485
-75
-1% -$20.2K 0.56% 50
2020
Q4
$1.36M Hold
5,560
0.54% 54
2020
Q3
$1.58M Sell
5,560
-1,200
-18% -$335K 0.75% 38
2020
Q2
$1.81M Hold
6,760
0.89% 31
2020
Q1
$2.14M Sell
6,760
-1,220
-15% -$370K 1.37% 22
2019
Q4
$2.37M Sell
7,980
-180
-2% -$49.9K 1.13% 29
2019
Q3
$1.9M Buy
8,160
+375
+5% +$87.3K 0.94% 33
2019
Q2
$1.82M Sell
7,785
-1,175
-13% -$271K 1% 31
2019
Q1
$2.12M Sell
8,960
-25
-0.3% -$7.87K 1.13% 24
2018
Q4
$2.7M Sell
8,985
-50
-0.6% -$16K 1.74% 10
2018
Q3
$3.19M Sell
9,035
-40
-0.4% -$13.8K 1.69% 10
2018
Q2
$2.63M Sell
9,075
-100
-1% -$28.1K 1.42% 14
2018
Q1
$2.51M Sell
9,175
-500
-5% -$155K 1.4% 14
2017
Q4
$3.08M Sell
9,675
-225
-2% -$72.2K 1.65% 10
2017
Q3
$3.1M Buy
9,900
+100
+1% +$29.6K 1.94% 9
2017
Q2
$2.66M Hold
9,800
1.93% 9
2017
Q1
$2.68M Sell
9,800
-180
-2% -$50.9K 2.13% 9
2016
Q4
$2.83M Sell
9,980
-75
-0.7% -$22.2K 2.71% 6
2016
Q3
$3.15M Buy
10,055
+100
+1% +$29.6K 2.88% 6
2016
Q2
$2.41M Sell
9,955
-100
-1% -$26.4K 2.36% 8
2016
Q1
$2.62M Sell
10,055
-1,750
-15% -$462K 2.65% 6
2015
Q4
$3.62M Buy
11,805
+400
+4% +$115K 3.09% 5
2015
Q3
$3.33M Buy
11,405
+25
+0.2% +$8.26K 2.92% 6
2015
Q2
$4.6M Buy
11,380
+500
+5% +$201K 3.61% 4
2015
Q1
$4.59M Sell
10,880
-390
-3% -$154K 3.78% 4
2014
Q4
$3.83M Buy
11,270
+1,665
+17% +$539K 3.25% 4
2014
Q3
$3.18M Sell
9,605
-160
-2% -$52.8K 2.73% 7
2014
Q2
$3.08M Sell
9,765
-400
-4% -$120K 2.54% 6
2014
Q1
$3.11M Sell
10,165
-3,600
-26% -$1.14M 2.88% 4
2013
Q4
$3.85M Buy
+13,765
New +$3.56M 2.56% 5

Other funds holding BIIB

Fernwood Investment Management's BIIB Position: Q4 2024 in Review

Fernwood Investment Management reduced its Biogen (BIIB) stake by 3.6% in Q4 2024, selling an estimated $16.9K and leaving 2,660 shares worth $407K. The position accounts for 0.14% of the portfolio, ranked #119.

Fernwood Investment Management first reported a position in BIIB in Q4 2013 and has held it in 45 quarters since. The position peaked at $4.6M in Q2 2015. 875 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Fernwood Investment Management held 2,660 shares of Biogen worth $407K as of Q4 2024.
  • Fernwood Investment Management sold 100 Biogen shares in Q4 2024, an estimated $16.9K.
  • Biogen made up 0.14% of Fernwood Investment Management's portfolio in Q4 2024, its #119 holding.
  • Fernwood Investment Management first reported a position in Biogen in Q4 2013 and has held it in 45 quarters since.
  • Fernwood Investment Management's Biogen position peaked at $4.6M in Q2 2015.
  • 875 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.